640 vs TQR: Side-by-Side Comparison
Compare China Resources Pharmaceutical Group Limited (640) and Beijing Tong Ren Tang Chinese Medicine Company Limited (TQR) side by side: market cap EUR 2.97B vs EUR 593.47M, P/E 5.9 vs 14.0. Financials, growth and model signals on Bullrun.
| Metric | 640 | TQR |
|---|---|---|
| Company | China Resources Pharmaceutical Group Limited | Beijing Tong Ren Tang Chinese Medicine Company Limited |
| Country / Exchange | Hong Kong · F | Hong Kong · F |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
| Market cap | EUR 2.97B | EUR 593.47M |
| P/E ratio | 5.9 | 14.0 |
| Dividend yield | 5.14% | 5.85% |
| Valuation model | — | — |
| Revenue (latest FY) | EUR 269.57B | EUR 1.61B |
| Revenue growth YoY | +4.6% | +5.7% |
| Net income | EUR 4.05B | EUR 500.28M |
| Gross margin | 16.5% | 66.1% |
| Diluted EPS | 0.64 | 0.60 |